Interactions of Rabconnectin-3 with Cav2 calcium channels.


Journal

Molecular brain
ISSN: 1756-6606
Titre abrégé: Mol Brain
Pays: England
ID NLM: 101468876

Informations de publication

Date de publication:
28 06 2019
Historique:
received: 22 05 2019
accepted: 17 06 2019
entrez: 30 6 2019
pubmed: 30 6 2019
medline: 2 6 2020
Statut: epublish

Résumé

This study describes the interaction between Cav2 calcium channels and Rabconnectin-3, a di-subunit protein that is associated with synaptic vesicles. Immunostaining reveals that both Rabconnectin-3α (RB-3α) and Rabconnectin-3β (RB-3β) are colocalized in mouse hippocampal neurons. Co-immunoprecipitations from brain tissue is consistent with the formation of a protein complex between RB-3α and RB-3β and both Cav2.2 and the related Cav2.1 calcium channel. The coexpression of either RB-3α or RB-3β with Cav2.2 calcium channels in tsA-201 cells led to a reduction in Cav2.2 current density without any effects on the voltage-dependence of activation or inactivation. Coexpression of both Rabconnectin-3 subunits did not cause an additive effect on current densities. Finally, the presence of Rabconnectin-3 did not interfere with μ-opioid receptor mediated Gβγ modulation of Cav2.2 channels. Altogether, our findings show that Rabconnectin-3 has the propensity to regulate calcium entry mediated by Cav2.2 channels.

Identifiants

pubmed: 31253182
doi: 10.1186/s13041-019-0483-y
pii: 10.1186/s13041-019-0483-y
pmc: PMC6599304
doi:

Substances chimiques

Cav2 protein, mouse 0
Caveolin 2 0
DMXL2 protein, mouse 0
Nerve Tissue Proteins 0
GTP-Binding Proteins EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

62

Références

Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1512-6
pubmed: 9037084
Eur J Med Genet. 2011 Jan-Feb;54(1):86-8
pubmed: 20870045
Neuron. 2014 Apr 2;82(1):24-45
pubmed: 24698266
Cold Spring Harb Perspect Biol. 2012 Jan 01;4(1):a011353
pubmed: 22068972
J Biol Chem. 2003 Feb 7;278(6):4258-67
pubmed: 12458203
Hum Mol Genet. 2015 Feb 15;24(4):987-93
pubmed: 25296916
Cell Rep. 2017 Mar 14;18(11):2715-2728
pubmed: 28297674
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4035-9
pubmed: 9520488
J Biochem Mol Biol. 2007 May 31;40(3):302-14
pubmed: 17562281
Protein Cell. 2011 Mar;2(3):202-14
pubmed: 21468892
Mol Biol Cell. 2016 Nov 1;27(21):3329-3341
pubmed: 27605709
Biophys J. 1996 Nov;71(5):2509-21
pubmed: 8913590
Neuron. 2008 May 22;58(4):557-70
pubmed: 18498737
J Pharmacol Sci. 2003 Jun;92(2):79-83
pubmed: 12832834
Methods Enzymol. 2005;403:401-7
pubmed: 16473606
Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7363-8
pubmed: 8692999
Int J Mol Sci. 2019 May 06;20(9):
pubmed: 31064106
J Gen Physiol. 2009 Mar;133(3):327-43
pubmed: 19237593
PLoS Biol. 2014 Sep 23;12(9):e1001952
pubmed: 25248098
EMBO Rep. 2015 Aug;16(8):923-38
pubmed: 26160654
Neuron. 2017 Dec 20;96(6):1317-1326.e4
pubmed: 29198756
J Neurosci Res. 2018 Mar;96(3):335-347
pubmed: 28699241
Protein J. 2018 Oct;37(5):391-406
pubmed: 30069656
J Biol Chem. 2002 Mar 22;277(12):9629-32
pubmed: 11809763
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5405-10
pubmed: 9144250
Front Cell Neurosci. 2013 Jun 28;7:101
pubmed: 23874268
Front Physiol. 2014 Jun 03;5:209
pubmed: 24917826
Biochim Biophys Acta. 2013 Jul;1828(7):1629-43
pubmed: 23063655
J Neurosci. 2007 Jan 10;27(2):265-9
pubmed: 17215385
Genes Cells. 2003 Jun;8(6):537-46
pubmed: 12786944
Front Mol Neurosci. 2018 Jul 16;11:213
pubmed: 30061813
Cold Spring Harb Perspect Biol. 2011 Aug 01;3(8):a003947
pubmed: 21746798
Nature. 1997 Jan 30;385(6615):446-50
pubmed: 9009193
J Biol Chem. 2010 Aug 6;285(32):24968-76
pubmed: 20522554
Eur J Neurosci. 2007 Aug;26(3):547-59
pubmed: 17686036
Genet Med. 2017 May;19(5):553-558
pubmed: 27657680
Mov Disord. 1995 Jul;10(4):496-9
pubmed: 7565832

Auteurs

Maria A Gandini (MA)

Department of Physiology and Pharmacology, Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, T2N 4N1, Canada.

Ivana A Souza (IA)

Department of Physiology and Pharmacology, Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, T2N 4N1, Canada.

Jing Fan (J)

Department of Physiology and Pharmacology, Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, T2N 4N1, Canada.

Katherine Li (K)

Department of Physiology and Pharmacology, Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, T2N 4N1, Canada.

Decheng Wang (D)

Department of Physiology and Pharmacology, Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, T2N 4N1, Canada.

Gerald W Zamponi (GW)

Department of Physiology and Pharmacology, Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, T2N 4N1, Canada. zamponi@ucalgary.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH